Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
52
NCT00353756
Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2006
Completion: Sep 30, 2007